Stockscreener 앱 받기
56.19
7.17%
-4.34
시간 외 거래:
56.14
-0.05
-0.09%
Protagonist Therapeutics Inc (PTGX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
80.42%
5.546
|
28.32 | 4.675 | 4.167 | 254.95 |
Operating Expenses
|
0.09%
47.59
|
47.63 | 46.13 | 42.96 | 48.64 |
| Benefits Costs and Expenses |
0.42%
40.15
|
39.98 | 38.30 | 35.46 | 44.29 |
| Costs And Expenses |
0.42%
40.15
|
39.98 | 38.30 | 35.46 | 44.29 |
| Operating Income/Loss |
117.72%
-42.04
|
-19.31 | -41.45 | -38.79 | 206.31 |
| Income/Loss From Continuing Operations Before Tax |
196.86%
-34.60
|
-11.65 | -33.63 | -31.29 | 210.67 |
| Income Tax Expense/Benefit |
0.172
|
- | -0.42 | -0.676 | 3.326 |
| Income/Loss From Continuing Operations After Tax |
198.34%
-34.77
|
-11.65 | -33.21 | -30.62 | 207.34 |
|
Net Income/Loss
|
198.34%
-34.77
|
-11.65 | -33.21 | -30.62 | 207.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.87%
63.51
|
62.96 | 61.77 | 61.31 | 60.86 |
| Diluted Average Shares |
0.87%
63.51
|
62.96 | 61.77 | 61.31 | 63.60 |
| Basic Earnings Per Share |
189.47%
-0.55
|
-0.19 | -0.54 | -0.50 | 3.41 |
| Diluted Earnings Per Share |
189.47%
-0.55
|
-0.19 | -0.54 | -0.50 | 3.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.75%
0.00%
자본화:
|
볼륨(24시간):